After shutting down its trial for a leukemia conditioning agent due to a patient death, Magenta’s review of strategic alternatives concludes with a combination with complement inhibitor-focused Dianthus.

Pediatric and geriatric patients are continuing to struggle to access liquid-dose amoxicillin in Canada, prompting the health regulator to issue an emergency import authorization to local firm Juno Pharmaceuticals.

A year on from being spun-out of Perrigo and acquired by private equity, liquid generics specialist Rosemont Pharmaceuticals has revealed new details of the UK-based firm’s operations.